title: CYPHER versus TAXUS stent for bifurcation lesions beyond 30 days-long-term follow-up results.
authors.forename: Chi-Hang
authors.initials: CH
authors.lastname: Lee
authors.forename: Adrian
authors.initials: A
authors.lastname: Low
authors.forename: Jimmy
authors.initials: J
authors.lastname: Lim
authors.forename: Hwee-Bee
authors.initials: HB
authors.lastname: Wong
authors.forename: Yean-Teng
authors.initials: YT
authors.lastname: Lim
authors.forename: Huay-Cheem
authors.initials: HC
authors.lastname: Tan
mesh_terms: D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000628:therapy*; D016503:Drug Delivery Systems; D004867:Equipment Design; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents; D013997:Time Factors
chemical_list: D017239:Paclitaxel; D020123:Sirolimus